TrialJournal of clinical oncology : official journal of the American Society of Clinical Oncology2024

Pembrolizumab Plus Carboplatin and Paclitaxel as First-Line Therapy for Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma (KEYNOTE-B10): A Single-Arm Phase IV Trial.

Marcin Dzienis et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.